SAMD5 and breast carcinoma: In vivo studies using a xenograft tumor model in nude mice demonstrated that SAMD5 overexpression reduced tumor weight and volume, with these effects being partially reversed by PLK1 overexpression, highlighting the interaction between SAMD5 and PLK1 in modulating breast carcinoma progression.